Table 3 Univariate analysis of the patients who reached the composite end point and the patients who failed to reach the composite end point
Parameter | Patients who reached the composite end point n = 96 | Patients who failed to reach the composite end point n = 17 | P |
|---|---|---|---|
Age | 54.0 (45.2–62.0) | 59.0 (52.0–73.5) | 0.042 |
Female | 48 (50.0%) | 4 (23.5%) | 0.044 |
Comorbidity | 28 (29.2%) | 11 (64.7%) | 0.004 |
Hypertension | 19 (19.8%) | 7 (41.2%) | 0.053 |
Diabetes | 9 (9.4%) | 4 (23.5%) | 0.092 |
Coronary heart disease | 4 (4.2%) | 3 (17.6%) | 0.034 |
COPD | 4 (4.2%) | 2 (11.8%) | 0.198 |
Cerebrovascular disease | 2 (2.1%) | 2 (11.8%) | 0.046 |
Time of onset | 7.0 (5.0–10.0) | 7.0 (6.5–10.0) | 0.499 |
Body temperature | 38.4 (37.6–39.0) | 38.9 (38.2–39.4) | 0.041 |
WBC | 5.28 (4.02–7.22) | 8.43 (6.58–16.21) | 0.001 |
LYM | 1.12 (0.78–1.54) | 0.67 (0.55–1.03) | 0.001 |
PLT | 201.0 (159.2–258.5) | 191.0 (124.0–213.5) | 0.086 |
ALT | 23.0 (15.0–34.7) | 29.7 (21.5–74.0) | 0.065 |
AST | 20.6 (17.0–27.0) | 36.0 (18.0–45.4) | 0.029 |
Cr | 76.6 ± 22.2 | 88.6 ± 30.5 | 0.056 |
PT | 11.4 ± 1.2 | 12.9 ± 1.6 | < 0.001 |
DD | 172.0 (107.9–285.5) | 851.0 (217.0–9954.5) | < 0.001 |
GC | 43 (44.8%) | 14 (82.4%) | 0.004 |
IVIG | 35 (36.5%) | 12 (70.6%) | 0.008 |